TP53 and Down syndrome: These guidelines have been elaborated by members of the European Reference Network (ERN) on the Genetic Tumour Risk Syndromes (GENTURIS) in order to integrate the available information with clinical utility and to assist health care professionals in the identification and management of patients with germline disease-causing TP53 variants, causing heritable TP53-related cancer (hTP53rc) syndrome.